Crescendo Biologics Appoints Matthew Roe as Chief Business Officer

24-Jun-2011 - United Kingdom

Crescendo Biologics Limited announced the appointment of Matthew Roe as Chief Business Officer. Matthew joins Crescendo from Genzyme Corporation where he was Senior Director, Business Development & Licensing.

During a 23-year career at Genzyme, Matthew was active in licensing, alliance management, acquisition, divestment, and sales and marketing, and saw the corporation develop from an entrepreneurial start-up to a leading multi-national biotechnology company. He negotiated and managed multiple agreements for drug delivery technologies in the USA, Europe and Japan and was also a core team member on the divestment of Genzyme’s Pharmaceuticals business.

Other news from the department people

Most read news

More news from our other portals

So close that even
molecules turn red...